Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...

Respect Summer's Scorching Heat, Experts Warn

The human body is no match for extreme heat, and scorching temperatures seem to be the rule rather than the exception these days."It's hard to think of...

CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections

Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in...

More Women Than Men Experience Nonphysical Violence in Health Care Workforce

Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience...

CDC: Five Cases of Neonatal Enterovirus Infection Identified in San Diego

Five cases of neonatal enterovirus infection have been reported in San Diego, highlighting the risks and need for timely identification and treatment,...

Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later

Three of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1...

Thousands of Hospital Patients in Oregon May Have Been Exposed to Hepatitis, HIV

After an anesthesiologist may have exposed thousands of people treated at several hospitals in Oregon to hepatitis and HIV, those patients are being advised...

Fake Botox Shots Land 13 Women in Hospital

Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator,...

New Report Calls for More Research on Women's Health Issues

A new report finds research is sorely lacking on how chronic illnesses affect women, and it urged government agencies to do more to investigate how these...

Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target are Prostate Cancer Patients Resistant to Hormone Therapy

SEOUL, South Korea, July 11, 2024. ADM Korea, a subsidiary of Hyundai Bioscience, announced on the 8th that the first clinical trial target population...

AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease

Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...

Osteoarthritis Raises Risk of Other Chronic Health Conditions

Osteoarthritis could nearly triple a person’s risk of developing a multitude of other chronic illnesses, a new two-decade study finds. People with...

Read more news...

Recently Added

Recently added consumer and prescribing information: Pyzchiva, Ahzantive, Ohtuvayre, Sofdra, Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Kisunla Kisunla (donanemab-azbt) is an amyloid beta-directed antibody indicated for the treatment of early symptomatic Alzheimer’s disease.
  • Ahzantive Ahzantive (aflibercept-mrbb) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
  • Nypozi Nypozi (filgrastim-txid) is a leukocyte growth factor biosimilar to Neupogen indicated for the treatment of neutropenia, neutropenia...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development